Increased myelinating capacity of embryonic stem cell derived oligodendrocyte precursors after treatment by interleukin-6/soluble interleukin-6 receptor fusion protein
- 1 March 2006
- journal article
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 31 (3) , 387-398
- https://doi.org/10.1016/j.mcn.2005.10.014
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Stem cell repair of central nervous system injuryJournal of Neuroscience Research, 2002
- Embryonic Stem Cell-Derived Glial Precursors: A Source of Myelinating TransplantsScience, 1999
- A bioactive designer cytokine for human hematopoietic progenitor cell expansionNature Biotechnology, 1997
- Translocation of myelin basic protein mRNA in oligodendrocytes requires microtubules and kinesinCell Motility, 1997
- Ciliary Neurotrophic Factor Enhances the Rate of Oligodendrocyte GenerationMolecular and Cellular Neuroscience, 1996
- CNS myelinogenesis in vitro: Time course and pattern of rat oligodendrocyte developmentJournal of Neuroscience Research, 1995
- Conditionally Immortalized Oligodendrocyte Cell Lines Migrate to Different Brain Regions and Elaborate 'Myelin-Like' Membranes after Transplantation into Neonatal Shiverer Mouse BrainsDevelopmental Neuroscience, 1995
- A crucial role for neurotrophin-3 in oligodendrocyte developmentNature, 1994
- Posttranscriptional Regulation of Myelin Protein Gene ExpressionAnnals of the New York Academy of Sciences, 1991
- Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells.Proceedings of the National Academy of Sciences, 1990